• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡唑类CB1和CB2配体的N1和C5取代环烷基类似物的合成、生物学评价及结构研究

Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.

作者信息

Krishnamurthy Mathangi, Li Wei, Moore Bob M

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee-Memphis, 847 Monroe Avenue, Memphis, TN 38103, USA.

出版信息

Bioorg Med Chem. 2004 Jan 15;12(2):393-404. doi: 10.1016/j.bmc.2003.10.045.

DOI:10.1016/j.bmc.2003.10.045
PMID:14723958
Abstract

A series of N1 and C5 substituted cycloalkyl and C5 4-methylphenyl analogues of the N-(piperidin-1-yl)-4-methyl-1H-pyrazole-3-carboxamide class of cannabinoid ligands were synthesized. The analogues were evaluated for CB1 and CB2 receptor binding affinities and receptor subtype selectivity. The effects of pyrazole substitution on ligand conformation and as such receptor affinities was not readily apparent; therefore, the geometries of the N1 and C5 substituents relative to the pyrazole ring were studied using high field NMR spectroscopy and systematic molecular mechanics geometry searches. An analysis of the relative ring geometries and functional group orientations provides new insight into the structural requirements of the CB1 and CB2 ligand binding pocket.

摘要

合成了一系列N-(哌啶-1-基)-4-甲基-1H-吡唑-3-甲酰胺类大麻素配体的N1和C5取代的环烷基以及C5 4-甲基苯基类似物。对这些类似物进行了CB1和CB2受体结合亲和力以及受体亚型选择性的评估。吡唑取代对配体构象以及受体亲和力的影响并不明显;因此,使用高场核磁共振光谱和系统的分子力学几何结构搜索研究了N1和C5取代基相对于吡唑环的几何结构。对相对环几何结构和官能团取向的分析为CB1和CB2配体结合口袋的结构要求提供了新的见解。

相似文献

1
Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.吡唑类CB1和CB2配体的N1和C5取代环烷基类似物的合成、生物学评价及结构研究
Bioorg Med Chem. 2004 Jan 15;12(2):393-404. doi: 10.1016/j.bmc.2003.10.045.
2
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.三环吡唑。3. 大麻素拮抗剂8-氯-1-(2',4'-二氯苯基)-N-哌啶-1-基-1,4,5,6-四氢苯并[6,7]环庚并[1,2-c]吡唑-3-甲酰胺类似物的合成、生物学评价及分子模拟
J Med Chem. 2005 Nov 17;48(23):7351-62. doi: 10.1021/jm050317f.
3
Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.利莫那班吡唑3 - 甲酰胺部分的生物电子等排体替换。一系列新型恶二唑类作为CB1大麻素受体拮抗剂。
Org Biomol Chem. 2008 Sep 21;6(18):3399-407. doi: 10.1039/b807648k. Epub 2008 Jul 23.
4
3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.大麻素受体亚型CB1和CB2的芳基吡唑拮抗剂的3D-QSAR研究。一种核磁共振和比较分子场分析相结合的方法。
J Med Chem. 2006 Jan 26;49(2):625-36. doi: 10.1021/jm050655g.
5
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.拮抗剂N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺与CB1大麻素受体的分子相互作用
J Med Chem. 2002 Mar 28;45(7):1447-59. doi: 10.1021/jm010267o.
6
Novel pyrrolocycloalkylpyrazole analogues as CB ligands.新型吡咯并环烷基吡唑类似物作为 CB 配体。
Chem Biol Drug Des. 2018 Jan;91(1):181-193. doi: 10.1111/cbdd.13069. Epub 2017 Jul 29.
7
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an effective scaffold for the design of either CB1 or CB2 receptor ligands.1-芳基-5-(1H-吡咯-1-基)-1H-吡唑-3-甲酰胺:设计 CB1 或 CB2 受体配体的有效支架。
Eur J Med Chem. 2011 Nov;46(11):5641-53. doi: 10.1016/j.ejmech.2011.09.037. Epub 2011 Sep 29.
8
Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.新型经典大麻素的合成与测试:探索CB1和CB2受体的侧链配体结合口袋
Bioorg Med Chem. 2003 Jul 17;11(14):3121-32. doi: 10.1016/s0968-0896(03)00238-4.
9
Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.N-(哌啶基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(SR141716)的构象受限类似物:设计、合成、计算分析及生物学评价
J Med Chem. 2008 Jun 26;51(12):3526-39. doi: 10.1021/jm8000778.
10
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.三环吡唑。第6部分。苯并呋喃并[3,2 - c]吡唑:一种用于CB2选择性配体的通用结构。
Eur J Med Chem. 2014 Jul 23;82:281-92. doi: 10.1016/j.ejmech.2014.05.055. Epub 2014 May 24.

引用本文的文献

1
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results.将利莫那班和芬太尼结合于单一制剂:制备及药理学结果。
Drug Des Devel Ther. 2014 Feb 20;8:263-77. doi: 10.2147/DDDT.S55045. eCollection 2014.
2
5-Amino-3-anilino-1H-pyrazole-4-carbonitrile.5-氨基-3-苯胺基-1H-吡唑-4-腈
Acta Crystallogr Sect E Struct Rep Online. 2012 Sep 1;68(Pt 9):o2784. doi: 10.1107/S1600536812036045. Epub 2012 Aug 25.
3
In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.
计算机模拟研究人类大麻素受体-1 与其拮抗剂的相互作用。
J Mol Model. 2012 Aug;18(8):3831-45. doi: 10.1007/s00894-012-1381-8. Epub 2012 Mar 9.
4
3-(4-Meth-oxy-phen-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde.3-(4-甲氧基苯基)-1-苯基-1H-吡唑-4-甲醛
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o2962-3. doi: 10.1107/S1600536811041808. Epub 2011 Oct 12.
5
3-(4-Bromo-phen-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde.3-(4-溴苯基)-1-苯基-1H-吡唑-4-甲醛
Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 1;67(Pt 10):o2650. doi: 10.1107/S1600536811036841. Epub 2011 Sep 17.
6
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.内源性大麻素对药物强化、依赖和成瘾相关行为的影响。
Pharmacol Ther. 2011 Dec;132(3):215-41. doi: 10.1016/j.pharmthera.2011.06.005. Epub 2011 Jul 18.
7
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.用于治疗精神兴奋剂成瘾的基于假设的药物发现。
Curr Drug Abuse Rev. 2008 Nov;1(3):303-27. doi: 10.2174/1874473710801030303.